Regional Health Properties, Inc. (RHE) Stock Skyrocketing as Pandemic Regulations Ease Up
Regional Health Properties, Inc. (RHE) stock prices were up a staggering 90.39% during the course of the trading day on May 5th, 2021, bringing the price per share up to USD$18.91. Promising Rent Collection Reports As of December 31st, 2020, RHE had collected 80% of contractual cash due for the fourth quarter of 2020 and […]
Clovis Oncology, Inc. (CLVS) Stock Trending Up Following Disclosure of Promising Q1 2021 Financial Reports
Clovis Oncology, Inc. (CLVS) stock prices were up a promising 8.89% shortly after the trading day commenced on May 5th, 2021, bringing the price per share up to USD$6.00. Comparative Decrease in Revenue CLVS reported USD$38.1 million in global net product revenues derived from the company’s flagship Rubraca in the first quarter of the fiscal […]
BioLineRX Ltd (BLRX) Stock Skyrockets Following Immense Success of Phase 3 GENESIS Clinical Trial
BioLineRx Ltd. (BLRX) stock prices skyrocketed by 52.98% as of market close on May 3rd 2021, bringing the price per share up to USD$4.88 at the end of the trading day. Subsequent pre-market fluctuations have seen the stock surge another 16.6% to hit USD$5.69. Phase 3 GENESIS trial BLRX announced on May 4th, 2021 the […]
Cocrystal Pharma, Inc. (COCP) Stock Skyrocketed Following Promising Updates on Covid-19 Drug Development
Cocrystal Pharma, Inc. (COCP) stock prices were up by a monumental 72.58% as of the market closing on may 4th 2021, bringing the price per share up to USD$2.14 at the end of the trading day. Subsequent pre-market fluctuations saw the stock fall by a significant 22.9%, bringing it down to USD$1.65. Covid-19 Treatment Program […]
Savara Inc. (SVRA) Stock Trending Down as Phase 3 of IMPALA 2 Trial Expected to Commence Soon
Savara Inc. (SVRA) stock prices were down by 3.95% as of the market closing on May 4th 2021, bringing the price per share down to USD$1.70 at the end of the trading day. 11th Hour Failure SVRA announced near the end of 2020 that the Phase 3 trial of AeroVanc did not meet its primary […]
Amgen, Inc. (AMGN) Stock Prices Undergo Volatility as Global Pandemic on Verge of Easing Up
Amgen, Inc. (AMGN) stock prices were down a marginal 0.15% as of market close on April 27th, 2021, inching the price down to USD$255.13. Subsequent pre-market fluctuations saw the stock price fall by 3.38%, bringing the price per share down to USD$246.50. Total Revenues Suffer The COVID-19 pandemic has been devastating for Amgen since its […]
Cassava Sciences, Inc. (SAVA) Stock Prices on the Rise After Success of Clinical Trials
Cassava Sciences, Inc. (SAVA) stock prices were up 5.61% as of market close on April 26th 2021, bringing the price per share up to USD$41.81 at the end of the trading day. Subsequent current market fluctuations saw the stock price climb 3.78% to it USD$43.39. SAVA’s Net Loss In their recently disclosed financial reports for […]
Aldeyra Therapeutics, Inc. (ALDX) Stock Prices Surge After News of Clinical Trial Success
Aldeyra Therapeutics, Inc. (ALDX) stock prices were up 4.81% as of market close on April 26th, 2021 bringing the price per share up to USD$11.11. Subsequent pre-market fluctuations have seen the stock price surge by 21.78%, bringing it up to USD$13.53. Success of INVIGORATE Clinical Trial The sharp increase in ALDX stock prices came hot […]
Teligent, Inc. (TLGT) Stock Prices Trend Up as Company Consolidates its Financials and Hires New Senior Management
Teligent, Inc. (TLGT) stock prices were up 3.69% as of market close on April 26th, 2021, bringing the price per share up to USD$0.6010. Subsequent pre-market fluctuations saw the stock surge 12.31%, bumping it up to USD$0.68. Conversion of Outstanding Debt January 27th, 2021 saw the company’s Series C noteholders exchange the entirety of their […]
